Scarica l'app Stockscreener
3.11
0.96%
-0.02
Dna X Inc Borsa (SONM) Ultime notizie
Press Release Service: Researchers Gain Faster Access to Complex DNA as Integrated DNA Technologies and Ansa Biotechnologies Expand Ordering Platform - CRISPR Medicine News
Sonim Technologies Maintains Nasdaq Compliance Amid Monitoring Period - The Globe and Mail
DNA regained Nasdaq equity compliance but faces one-year mandatory monitor - TradingView
How DNA's Double Helix Structure Was Discovered - Britannica
SONM Q3 2024 Earnings: Loss Narrower Than Expected, Shares Rise 5.8%Profit Recovery Report - vinanet.vn
Sonim Technologies Adopts Cash-Based Director Compensation Structure - The Globe and Mail
DNA awards Substitute Cash Grants to board including CEO Mike Mulica - TradingView
DNA X (SONM) turns to cash after equity plan runs out of shares - Stock Titan
Restriction-enzyme DNA fingerprinting method explained - Britannica
DNA X: Q2 Earnings Snapshot - AOL.com
DNA X, Inc. Reports Second Quarter 2026 Financial Results - The Manila Times
DNA X Q2 EPS improves to $(0.91) from $(14.15) YoY - scanx.trade
DNA X, Inc. 2Q 2026: Revenue $0 EPS $(0.92) — 10-Q Summary - TradingView
SONM: Net income surged to $5.1M as the company pivoted to crypto trading and raised $5M in new capital - TradingView
DNA X (Nasdaq: SONM) profits from phone sale while crypto platform is in the red - Stock Titan
C&F Financial Corporation Announces Quarterly Dividend - The Manila Times
Beam Global Reports Second Quarter 2026 Operating Results - The Manila Times
VVC Exploration Corporation Files Annual Financial Statements - The Manila Times
DNA X raised $5 million after its quarter ended, while its trading platform had no revenue - Stock Titan
DNA (SONM) Quarter in Focus: The Bottom-Line Figure Outpaces Its Comparison in the Latest Session; Market Reaction: The Stock Ends Down 0.60% in Latest TradingGuidance Update - vinanet.vn
12 Information Technology Stocks Moving In Monday's After-Market Session - Benzinga
Aon plc (AON) Holds Near $355.83 as Insurance Broker Consolidates Between Support and ResistanceHigh Volume Node - Vinanet
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Analysts Just Slashed This Year's Revenue Estimates By 22% - simplywall.st
Sonim Technologies delays quarterly filing amid consolidation - TipRanks
DNA X, Inc. (SONM) delays Q2 2026 filing but projects smaller net loss - Stock Titan
SONM Q2'26 Earnings: EPS estimate is 5.22 USD - TradingView
Creative Realities, Inc. (CREX) Stock Price, News, Quote & History - finance.yahoo.com
DNA X, Inc. (SONM) raises $2.5M and targets Nasdaq equity rule compliance - Stock Titan
DNA X, Inc. (SONM) investor Lytton discloses 6.8% stake in latest 13G/A - Stock Titan
DNA X Inc. (SONM) Holds Flat at $3.56 as Range-Bound Trading PersistsChannel Breakout - vinanet.vn
Integrated DNA Technologies Scientists Set New Performance Benchmark for CRISPR Off-Target Nomination - Yahoo Finance
Star Wars Zero Company is a very safe XCOM descendant, but its most interesting parts are found in its Midnight Suns DNA - PC Gamer
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Slammed 36% But Getting In Cheap Might Be Difficult Regardless - 富途牛牛
SONM Q3 2024 Earnings: Narrower-Than-Expected Loss Fails to Lift SharesPost-Announcement Reaction - vinanet.vn
DNA X, Inc. announced that it has received $5.000004 million in funding from DNA Holdings Venture, Inc. - marketscreener.com
DNA X Inc. (SONM) Slips 1.69% as Shares Test Key Support at $3.60Synthetic Short - vinanet.vn
Token Talk Inc. (DNAX) stock price, news, quote and history - Yahoo Finance UK
Ginkgo Bioworks (NYSE: DNA) plans Q2 2026 results presentation and Q&A - Stock Titan
DNA X, Inc. Revenue Breakdown – NASDAQ:SONM - TradingView
VEON Ltd. (VEON) stock price, news, quote and history - Yahoo Finance UK
VEON Ltd. (VEON) Stock Price, News, Quote & History - Yahoo! Finance Canada
YD Bio and EG BioMed Conclude Successful Exhibition at BIO Asia-Taiwan 2026, Highlighting Innovations in Ophthalmology, Oncology Diagnostics, and Clinical Services - The Manila Times
12 Information Technology Stocks Moving In Monday's Pre-Market Session - Benzinga
DNA Sequencing Market Size to Hit USD 57.39 Billion by 2035 - Precedence Research
SAY Q2 2026 Earnings: Significant EPS Miss Raises ConcernsEstimate Uncertainty - dars.gov.et
Sonim Technologies Strengthens Capital Structure With Preferred Financing - The Globe and Mail
12 Information Technology Stocks Moving In Thursday's After-Market Session - Benzinga
DNA X, Inc. Enters Securities Purchase Agreement and Designates Series B Preferred Stock in Major 2026 Transaction - Minichart
DNA X Raises $8.1 Million Via Series B Preferred; $5.0 Million Cash, $3.1 Million Note Cancelled - TradingView
YD Bio Expands U.S. Laboratory Footprint to 46 States, Strengthening DNA-Methylation Early Cancer Detection Operations - The Manila Times
SONM Q3 2024 Earnings: Narrower-Than-Expected Loss, Stock Gains 2.14%Consensus Miss Rate - dars.gov.et
Cisco Catalyst 9300 Series Switches from Cisco Systems Inc.subscription-first campus networking p - AD HOC NEWS
Nextera Library Preparation Kit from Takara Holdings Incstreamlined NGS workflows for busy labs - AD HOC NEWS
DNA X, Inc. announced that it expects to receive $4.999998 million in funding from DNA Holdings Venture, Inc. - marketscreener.com
Applied DNA Sciences Named B2i Digital Featured Company to Share BNB-Focused Treasury Shift with Investors - The National Law Review
Study: Gen-Z and Millennials Are Aging Faster Than Their Parents—With Alarming Health Consequences - inc.com
1.77%
8.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):